CRAWFORD VICTOR L.
Known title: CEO, Pharmaceutical SegmentCIK: 0001449780
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cardinal Health Hits Record Highs as Sector Strength Continues. Cardinal Health's stock has reached record highs, outperforming the broader market as the healthcare sector shows strong momentum. In corporate news, Senior Vice President Shane Abeyratne has joined the Customer Experience Advisory Board of Level AI. Meanwhile, market observers are looking ahead to the company's upcoming Q1 2027 earnings report and its position as a defensive option in the current economic environment.
Transaction History
| HSY | ▲ Buy | Grant | 99 | $0 | 4/1/2025 | View on chart |
| HSY | ▲ Buy | Grant | 114 | $0 | 3/15/2025 | View on chart |
| HSY | ▲ Buy | Grant | 252 | $0 | 1/1/2025 | View on chart |
| HSY | ▲ Buy | Grant | 221 | $0 | 10/1/2024 | View on chart |
| HSY | ▲ Buy | Grant | 232 | $0 | 7/1/2024 | View on chart |
| HSY | ▲ Buy | Grant | 220 | $0 | 4/1/2024 | View on chart |
| HSY | ▲ Buy | Grant | 271 | $0 | 1/1/2024 | View on chart |
| HSY | ▲ Buy | Grant | 211 | $0 | 10/1/2023 | View on chart |
| HSY | ▲ Buy | Grant | 170 | $0 | 7/1/2023 | View on chart |
| HSY | ▲ Buy | Grant | 168 | $0 | 4/1/2023 | View on chart |
| HSY | ▲ Buy | Grant | 183 | $0 | 1/1/2023 | View on chart |
| HSY | ▲ Buy | Grant | 179 | $0 | 10/1/2022 | View on chart |
| CAH | ▲ Buy | Grant | 17,150 | $0 | 8/15/2022 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 29,952 | $2.1M | 8/15/2022 | View on chart |
| CAH | ▲ Buy | Grant | 36,536 | $0 | 8/9/2022 | View on chart |
| HSY | ▲ Buy | Grant | 184 | $0 | 7/1/2022 | View on chart |
| HSY | ▲ Buy | Grant | 185 | $0 | 4/1/2022 | View on chart |
| HSY | ▲ Buy | Grant | 208 | $0 | 1/1/2022 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 4,391 | $226K | 11/15/2021 | View on chart |
| HSY | ▲ Buy | Grant | 235 | $0 | 10/1/2021 | View on chart |
| CAH | ▲ Buy | Grant | 21,277 | $0 | 8/15/2021 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 19,991 | $1.0M | 8/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HSY faces higher candy costs and mixed analyst outlook
Seasonal candy prices have risen sharply, which could pressure Hershey's margins as Halloween demand climbs. Analysts have adjusted price targets lower, with JP Morgan and TD Cowen maintaining neutral or buy views while reducing their forecasts. The company's dividend yield of about 2.5% keeps it in focus among defensive dividend stocks.
HSY faces higher candy costs and mixed analyst outlook. Seasonal candy prices have risen sharply, which could pressure Hershey's margins as Halloween demand climbs. Analysts have adjusted price targets lower, with JP Morgan and TD Cowen maintaining neutral or buy views while reducing their forecasts. The company's dividend yield of about 2.5% keeps it in focus among defensive dividend stocks.